MedPath

National Survey on Gastroesophageal Reflux Disease (GERD) Patients

Completed
Conditions
GERD
Registration Number
NCT00695838
Lead Sponsor
AstraZeneca
Brief Summary

The purpose of this observational study is to assess the impact of abdominal fat on severity and frequency of GERD symptoms .

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5084
Inclusion Criteria
  • Male or female > or = 18 years old
  • Patient with symptomatic GERD
  • Without PPI or H2 antagonist treatment during the 3 previous months
  • Agree to take part in this study
Read More
Exclusion Criteria
  • Pregnant women
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Waist circumferenceOnce
Secondary Outcome Measures
NameTimeMethod
Frequency of GERD symptomsOnce
GERD impact scaleOnce

Trial Locations

Locations (1)

Research Site

🇫🇷

Yvre L Eveque, France

© Copyright 2025. All Rights Reserved by MedPath